SCFFbxo9 and CK2 direct the cellular response to growth factor withdrawal via Tel2/Tti1 degradation and promote survival in multiple myeloma

Vanesa Fernández-Sáiz, Bianca Sabrina Targosz, Simone Lemeer, Ruth Eichner, Christian Langer, Lars Bullinger, Clemens Reiter, Julia Slotta-Huspenina, Sonja Schroeder, Anna Maria Knorn, Julia Kurutz, Christian Peschel, Michele Pagano, Bernhard Kuster, Florian Bassermann

Research output: Contribution to journalArticlepeer-review

74 Scopus citations

Abstract

The Tel2 (also known as Telo2) and Tti1 proteins control the cellular abundance of mammalian PIKKs and are integral components of mTORC1 and mTORC2. Here we report that Tel2 and Tti1 are targeted for degradation within mTORC1 by the SCFFbxo9 ubiquitin ligase to adjust mTOR signalling to growth factor availability. This process is primed by CK2, which translocates to the cytoplasm to mediate mTORC1-specific phosphorylation of Tel2/Tti1, subsequent to growth factor deprivation. As a consequence, mTORC1 is inactivated to restrain cell growth and protein translation whereas relief of feedback inhibition activates the PI(3)K/TORC2/Akt pathway to sustain survival. Significantly, primary human multiple myelomas exhibit high levels of Fbxo9. In this setting, PI(3)K/TORC2/Akt signalling and survival of multiple myeloma cells is dependent on Fbxo9 expression. Thus, mTORC1-specific degradation of the Tel2 and Tti1 proteins represents a central mTOR regulatory mechanism with implications in multiple myeloma, both in promoting survival and in providing targets for the specific treatment of multiple myeloma with high levels of Fbxo9 expression.

Original languageEnglish
Pages (from-to)72-81
Number of pages10
JournalNature Cell Biology
Volume15
Issue number1
DOIs
StatePublished - Jan 2013

Fingerprint

Dive into the research topics of 'SCFFbxo9 and CK2 direct the cellular response to growth factor withdrawal via Tel2/Tti1 degradation and promote survival in multiple myeloma'. Together they form a unique fingerprint.

Cite this